INSIGHTS ON CONTRACT PHARMA MANUFACTURING
-
Overcoming Challenges To High-Concentration Formulation Development
Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.
-
Global Experts, Local Presence: Strengthening Europe's Advanced Therapy Supply Chain
Ensure the seamless development and commercialization of your ATMPs in Europe with integrated supply chain solutions that optimize logistics, biostorage, and regulatory compliance.
-
The Gateway To Europe: How The Stevenage Supply Chain Hub Supports ATMP Development
Ensure seamless access to European clinical trials and markets with GMP-compliant logistics, regulatory support, and risk mitigation to protect the integrity of your advanced therapies.
-
How Our Recent Innovative Solutions Meet Today's Supply Chain Challenges
When advanced therapy organizations place innovation at the heart of their strategy for overcoming supply chain challenges, they ultimately prioritize the most important stakeholder — the waiting patient.
-
Bora Pharmaceuticals: A Future Focused CDMO
Specializing in formulation development, clinical and commercial manufacturing, and advanced packaging solutions, we bring expertise across a diverse range of dosage forms.
-
Who's In Charge? How To Ensure Effective Trial Oversight, Leadership
Gain valuable insights into the role of sponsor-side Clinical Operations leadership, the risks of over-relying on CROs, and key strategies for fostering collaboration between sponsors and partners.
-
One-Step SAR: Using High-Content Imaging To Drive Small Molecule Protein Degraders From Hit To Lead
Discover Curia’s cost-effective high-content immunofluorescence workflow using the Revvity Opera Phenix™ system to efficiently identify small molecule protein degraders with rich, multi-dimensional data.
-
The Question Of Quality: Digging Into Manufacturing Priorities For Viral Vectors
Addressing the complexities of viral vector manufacturing through strategic internalization, advanced technologies, and regulatory excellence is crucial for the future of gene therapies.
-
Developing Scalable, Global Solutions For Cell & Gene Manufacturing
Cell and gene therapies offer transformative potential for treating complex diseases, but their manufacturing and global delivery face significant challenges.
-
Streamline The Path To FIH Trials With Advanced Cell Line Development
Many CDMOs cannot handle complex recombinant proteins, which often require a CLD process fully integrated with other CDMO components, including analytics and formulation development.